Effects of Yeast (1,3)-(1,6)-Beta-Glucan on Severity of Upper Respiratory Tract Infections: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Subjects.
Study Design
- Type d'étude
- Randomized Controlled Trial
- Taille de l'échantillon
- 299
- Population
- None
- Durée
- 16.0 weeks
- Intervention
- Effects of Yeast (1,3)-(1,6)-Beta-Glucan on Severity of Upper Respiratory Tract Infections: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Subjects. 900 mg
- Comparateur
- Placebo
- Critère de jugement principal
- Blood pressure
- Direction de l'effet
- Positive
- Risque de biais
- Unclear
Abstract
OBJECTIVES: Each year, adults suffer about two to four upper respiratory tract infections (URTIs), mostly in winter. The aim of the study was to evaluate the effects of brewers' yeast (1,3)-(1,6)-beta-glucan on incidence and severity of upper respiratory tract infections (URTIs). METHODS: Generally healthy men and women (n = 299) reporting at least three URTIs during the previous year were randomized to receive either a placebo or 900 mg of yeast beta-glucan daily for 16 weeks during winter. In cases of acute URTI, the severity of URTI symptoms was assessed via the WURSS-21 questionnaire and the Jackson scale, and a clinical confirmation was implemented by the investigator. RESULTS: Overall, 70 subjects under placebo and 71 subjects under yeast beta-glucan experienced at least one clinically confirmed URTI episode. The global severity using WURSS-21 had been quite similar between the study groups (p = 0.5267), whereas during the first days of URTIs the severity was less pronounced in the yeast beta-glucan group. On the episode level, the severity of physical symptoms was significantly lower for all investigated time intervals up to 7 days under yeast beta-glucan (WURSS (Q2-11) (days 1-2: p = 0.0465, days 1-3: p = 0.0323, days 1-4: p = 0.0248, days 1-7: p = 0.0278), also confirmed for the Jackson scale). The reduction of severity was accompanied by a significant increase in the joy subscore of the Perceived Stress Questionnaire (PSQ20) (p = 0.0148). In addition, there was a reduction of systolic (p = 0.0458) and diastolic (p = 0.1439) blood pressure. CONCLUSION: Subjects supplementing with yeast beta-glucan benefit by a reduced severity of physical URTI symptoms during the first week of an episode, even though the incidence and global severity of common colds could not be altered in comparison to placebo. Furthermore, accompanying benefits in terms of blood pressure and mood were identified. Altogether, yeast beta-glucan supports the immune function.
En bref
Subjects supplementing with yeast beta-glucan benefit by a reduced severity of physical URTI symptoms during the first week of an episode, even though the incidence and global severity of common colds could not be altered in comparison to placebo.
Used In Evidence Reviews
Similar Papers
American journal of physiology. Regulatory, integrative and comparative physiology · 2004
Effects of moderate exercise and oat beta-glucan on innate immune function and susceptibility to respiratory infection.
Journal of dietary supplements · 2013
Baker's yeast beta glucan supplementation increases salivary IgA and decreases cold/flu symptomatic days after intense exercise.
Journal of sports sciences · 2006
Nutritional strategies to counter stress to the immune system in athletes, with special reference to football.
Medicine and science in sports and exercise · 2008
Beta-glucan, immune function, and upper respiratory tract infections in athletes.
American journal of physiology. Regulatory, integrative and comparative physiology · 2008
Benefits of oat beta-glucan on respiratory infection following exercise stress: role of lung macrophages.
American journal of physiology. Regulatory, integrative and comparative physiology · 2009